CXCL12 and frontotemporal dementia: The second group of researchers demonstrated that CSF concentrations of CXCL12 were significantly higher in patients with amyotrophic lateral sclerosis and multiple sclerosis, but were not altered in AD, spinal muscular atrophy, or frontotemporal dementia [33].